Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Cancer Prev Res (Phila). 2008 Nov;1(6):485–493. doi: 10.1158/1940-6207.CAPR-08-0149

Figure 3. HSP90 inhibitors suppress TS-mediated induction of CYP1A1 and CYP1B1 mRNA.

Figure 3

MSK-Leuk1 and KYSE450 cells were treated with the indicated concentrations of 17-AAG or celastrol for 2 h. Subsequently, cells received vehicle or TS for 3 h. RT-PCR was used to determine the amounts of CYP1A1 (panel A), CYP1B1 (panel B) and β-actin mRNAs.